SCHEMBL5886384

SCHEMBL5886384

CS(=O)(=O)Nc1cccc2c1ccc1nc3cccc(C(=O)O)c3nc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50
MMP2 P08253 1/20 0.47
KEAP1 Q14145 1/20 0.47
KMT2A Q03164 1/20 0.43
EP300 Q09472 1/20 0.42
KAT2B Q92831 1/20 0.42
KAT8 Q9H7Z6 1/20 0.42
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2D6 P10635 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C19 P33261 1/20 0.41
KDM1A O60341 1/20 0.40
ALOX15 P16050 1/20 0.40
HTT P42858 1/20 0.40
GLO1 Q04760 1/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5886323 0.84 ALDH1A1 (0.51) ALDH1A1KMT2ACYP1A2CYP2C9MAPT
SCHEMBL5886349 0.81 ALDH1A1 (0.54) ALDH1A1ALOX15ATML3MBTL1RAD52
SCHEMBL5886412 0.81 ALDH1A1 (0.48) ALDH1A1MMP2KMT2ACYP1A2CYP2C9
SCHEMBL5886347 0.80 ALDH1A1 (0.47) ALDH1A1KMT2ACYP1A2CYP2C9MAPT
SCHEMBL5886249 0.79 ALDH1A1 (0.58) ALDH1A1CYP1A2CYP2C9MAPTCYP2C19
SCHEMBL5886308 0.79 ALDH1A1 (0.54) ALDH1A1KMT2AMAPTATML3MBTL1
SCHEMBL5886374 0.78 ALDH1A1 (0.50) ALDH1A1MMP2CYP1A2CYP2C9MAPT
SCHEMBL5886240 0.78 ALDH1A1 (0.59) ALDH1A1KMT2ACYP1A2CASP7MAPT
SCHEMBL5886290 0.77 ALDH1A1 (0.58) ALDH1A1MMP2KMT2AMAPTL3MBTL1
SCHEMBL5886397 0.77 ALDH1A1 (0.58) ALDH1A1RAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7132419-B2 Pharmaceutical compounds XENOVA LIMITED (GB) 2006-11-07 US claimed
US-20050143383-A1 Pharmaceutical compounds XENOVA LIMITED (GB) 2005-06-30 US claimed
US-20030139409-A1 Benzo[A] [phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II XENOVA LIMITED (GB) 2003-07-24 US claimed
EP-1240148-A1 BENZO[A]PHENAZIN-11-CARBOXAMIDE DERIVATIVES AND THEIR USE AS JOINT INHIBITORS OF TOPOMERASE I AND II Xenova Limited (GB) 2002-09-18 EP claimed
WO-2001046157-A1 BENZO[A]PHENAZIN-11-CARBOXAMIDE DERIVATIVES AND THEIR USE AS JOINT INHIBITORS OF TOPOMERASE I AND II XENOVA LIMITED (GB) 2001-06-28 WO claimed
US-7132419-B2 Pharmaceutical compounds XENOVA LIMITED (GB) 2006-11-07 US disclosed
US-20050143383-A1 Pharmaceutical compounds XENOVA LIMITED (GB) 2005-06-30 US disclosed
US-20030139409-A1 Benzo[A] [phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II XENOVA LIMITED (GB) 2003-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143383-A1 Pharmaceutical compounds CHRNA10, OPRM1, SCN10A ALDH1A1 3766/4885MMP2 4699/4885KEAP1 3083/4885
US-20030139409-A1 Benzo[A] [phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II TOP1, TOP2A, TOP2B ALDH1A1 2334/4885MMP2 391/4885KEAP1 4198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.